100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4.2 TrustPilot
logo-home
Examen

NURS 661 Exam 2 – Complete Questions & Answers (2025/2026) | Advanced Pharmacology | Nursing Exam Guide

Puntuación
-
Vendido
-
Páginas
15
Grado
A+
Subido en
23-11-2025
Escrito en
2025/2026

This comprehensive study guide provides complete questions and verified answers for NURS 661 Exam 2, updated for the 2025/2026 academic year. Covering advanced pharmacology topics including drug classifications, therapeutic uses, side effects, contraindications, and patient safety considerations essential for advanced practice nursing.

Mostrar más Leer menos
Institución
NURS 661
Grado
NURS 661









Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Escuela, estudio y materia

Institución
NURS 661
Grado
NURS 661

Información del documento

Subido en
23 de noviembre de 2025
Número de páginas
15
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

Vista previa del contenido

NURS 661 EXAM 2 —a COMPLETE QUESTIONS &
ANSWERS (2025/2026)

Introduction

NURS 661 is the cornerstone didactic course for graduate psychiatric-mental health nursing students
advancing toward nurse-practitioner practice. Exam 2 evaluates mastery of evidence-based biological
and psychotherapeutic interventions across the lifespan. Domains tested include advanced
psychopharmacology (mechanisms, kinetics, adverse effects, interactions), neurobiological
underpinnings of DSM-5-TR disorders, evidence-based psychotherapy models, crisis and safety
planning, culturally responsive care, and the ethical / legal scope of the psychiatric-mental health NP.
Every question below is original, board-exam aligned, and written for the 2025/2026 academic year
to support A-level performance.



Question 1

Which second-generation antipsychotic possesses the highest affinity for the 5-HT2A receptor
relative to D2 and carries the lowest risk of dose-dependent prolactin elevation?
A. Risperidone
B. Olanzapine
C. Ziprasidone
D. Aripiprazole

Answer: D. Aripiprazole
Rationale: Aripiprazole is a D2 partial agonist with high 5-HT2A antagonism. Partial agonism stabilizes
dopamine pathways, preventing sustained prolactin elevation. Risperidone and olanzapine are
potent D2 blockers; ziprasidone’s ratio is lower.



Question 2

A 26-year-old with MDD begins sertraline 50 mg daily. After 6 weeks, Hamilton-D-17 score drops
from 22 to 18. Which neuroplastic change is most closely linked to this partial response?
A. Down-regulation of β-adrenergic receptors
B. Increased hippocampal BDNF expression
C. Decreased 5-HT1A autoreceptor density
D. Up-regulation of GABA-A subunits

Answer: B. Increased hippocampal BDNF expression
Rationale: SSRIs gradually raise brain-derived neurotrophic factor, promoting synaptogenesis and
neurogenesis—correlating with mood improvement. β-down-regulation occurs faster; 5-HT1A
changes are earlier; GABA up-regulation is less specific.



Question 3




pg. 1

, (Case) A patient on lithium 900 mg nightly for bipolar I presents with coarse tremor, nausea, and
serum lithium 1.4 mEq/L (normal 0.6–1.0). Which kinetic factor most likely explains this elevation?
A. Introduction of ibuprofen two weeks ago
B. Switch from twice-daily to once-daily dosing
C. Initiation of high-dose vitamin D
D. Patient began a low-sodium diet

Answer: A. Introduction of ibuprofen two weeks ago
Rationale: NSAIDs reduce renal blood flow and lithium clearance, raising levels within days. Once-
daily dosing does not alter steady-state AUC; vitamin D lacks kinetic interaction; low-sodium
increases reabsorption but NSAIDs have larger effect.



Question 4

Which cytochrome P450 enzyme contributes most to the primary active metabolite of clozapine?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C19

Answer: A. CYP1A2
Rationale: CYP1A2 forms norclozapine, which retains some efficacy. 3A4 contributes, but 1A2 is
dominant. Smoking induces 1A2, often requiring higher doses.



Question 5

During initiation of brexpiprazole, which monitoring parameter is unique compared with other
atypical antipsychotics?
A. Fasting lipid panel
B. A1C
C. Baseline CYP2D6 genotype
D. Prolactin

Answer: C. Baseline CYP2D6 genotype
Rationale: Brexpiprazole’s FDA labeling recommends genotype-guided dosing (reduce starting dose
by half in CYP2D6 poor metabolizers). Lipids, A1C, and prolactin are standard for all.



Question 6

(Case) A 34-year-old with treatment-resistant MDD receives intravenous ketamine 0.5 mg/kg. Within
2 hours, mood improves dramatically. Which receptor mechanism is most directly responsible for the
rapid antidepressant effect?
A. NMDA-receptor antagonism → increased glutamate burst → AMPA potentiation
B. Direct 5-HT2A agonism
C. Mu-opioid receptor agonism
D. GABA-A positive modulation




pg. 2
$12.99
Accede al documento completo:

100% de satisfacción garantizada
Inmediatamente disponible después del pago
Tanto en línea como en PDF
No estas atado a nada

Conoce al vendedor
Seller avatar
TutorAgness
5.0
(1)

Conoce al vendedor

Seller avatar
TutorAgness Chamberlain College Of Nursing
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
8
Miembro desde
1 año
Número de seguidores
5
Documentos
244
Última venta
2 semanas hace

5.0

1 reseñas

5
1
4
0
3
0
2
0
1
0

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes